The effects of simvastatin combined with different antioxidant vitamin regimens on serum lipid profile in patients with low HDL cholesterol levels;HDL kolesterol düzeyi düşük olan bireylerde statin tedavisine farkli antioksidan vitaminlerin eklenmesinin serum lipid profili üzerine etkisi

Anadolu Kardiyoloji Dergisi

Volumn 4, Issue 4, 2004, Pages 318-322

  Pirat, Bahar ^a   Korkmaz, Mehmet Emin ^a   Eroǧlu, Serpil ^a   Tayfun, Egemen ^a   Yildirir, Aylin ^a   Uluçam, Melek ^a   Özin, Bülent ^a   Müderrisoǧlu, Haldun ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Antioxidant vitamins; HDL cholesterol; Simvastatin

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS;

ADMINISTRATION, ORAL; ANTIOXIDANTS; ASCORBIC ACID; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; LIPIDS; MALE; SIMVASTATIN; TREATMENT OUTCOME; VITAMIN E;

EID: 10844219623     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation 1989; 79: 8-15.
2. Gordon DJ, Rifkind BM. High-density lipoprotein-the clinical implications of recent studies. N Engl J Med 1989; 321: 1311-6.
3. Saku K, Zhang B, Ohta T, Arakawa K. Quantity and function of high density lipoprotein as an indicator of coronary atherosclerosis. J Am Coll Cardiol 1999; 33: 436-43.
4. Foody JM, Ferdinand FD, Pearce GL, Lytle BW, Cosgrove DM, Sprecher DL. HDL cholesterol level predicts survival in men after coronary artery bypass graft surgery. Circulation 2000; 102(suppl III): III-90-4.
5. Parthasarathy S, Barnett J, Fong LG. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta 1990; 1044: 275-83.
6. Heinecke JW. Oxidative stress: new approaches to diagnosis and prognosis in atherosclerosis. Am J Cardiol 2003; 91(Suppl 3A): 12-6.
7. Riemersma RA, Oliver M, Elton RA, Alfthan G, Vartiainen E, Salo M. Plasma antioxidants and coronary heart disease: Vitamins C, and E, and selenium. Eur J Clin Nutr 1990; 44: 143-50.
8. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993; 328: 1444-9.
9. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328: 1450-6.
10. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347: 781-6.
11. Jialal I, Traber M, Devaraj S. Is there a vitamin E paradox? Curr Opin Lipidol 2001; 12: 49-53.
12. Salonen RM, Nyyssönen K, Kaikkonen J, et al. Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression The antioxidant supplementation in atherosclerosis prevention (ASAP) study. Circulation 2003; 107: 947-53.
13. Stein JH, Carlsson CM, Papcke-Benson K, et al. The effects of lipid-lowering and antioxidant vitamin therapies on flow-mediated vasodilation of the brachial artery in older adults with hypercholesterolemia. J Am Coll Cardiol 2001; 38: 1806-13.
14. Azen SP, Gian D, Mack WJ, et al. Effect of supplementary antioxidant vitamin intake on carotid arterial wall intima-media thickness in a controlled clinical trial of cholesterol lowering. Circulation 1996; 94: 2369-72.
15. Cheung MC, Zhao XQ, Chait A, Albers JJ, Brown BG. Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL. Arterioscler Thromb Vasc Biol 2001; 21: 1320-6.
16. Brown BG, Zhao XG, Chait A, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Eng J Med 2001; 345: 1583-92.
17. Collins R, Armitage J, Parish S, Sleight P, Peto R. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7-22.
18. Arrol S, Mackness MI, Durrington PN. Vitamin E supplementation increases the resistance of both LDL and HDL to oxidation and increases cholesteryl ester transfer activity. Atherosclerosis 2000; 150: 129-34.
19. Evans RW, Shaten BJ, Day BW, Kuller LH. Prospective association between lipid soluble antioxidants and coronary heart disease in men. Am J Epidemiol 1998; 147: 180-6.
20. Bunout D, Garrido A, Suazo M, et al. Effects of supplementation with folic acid and antioxidant vitamins on homocysteine levels and LDL oxidation in coronary patients. Nutrition 2000; 16: 107-10.
21. Baydas G, Yilmaz O, Celik S, Gursu MF. Effects of certain micronutrients and melatonin on plasma lipid and homocysteine levels in rats. Arch Med Res 2002; 33: 515-9.
22. Can C, Çinar MG, Koşay S, Akgün E. Vascular endothelial dysfunction associated with elevated serum homocysteine levels in rats adjuvant arthritis: effect of vitamin E administration. Life Sci 2002; 71: 401-10.
23. Bayes B, Pastor MC, Bonal J, Junca J, Romero R. Homocysteine and lipid peroxidation in haemodialysis: role of folic acid and vitamin E. Nephrol Dial Transplant 2001; 16: 2172-5.
24. Maxwell SR. Coronary artery disease-free radical damage, antioxidant protection and the role of homocysteine. Basic Res Cardiol 2000; 95 (Suppl 1): 165-71.
25. Palmer AM, Thomas CR, Gopaul N, et al. Dietary antioxidant supplementation reduces lipid peroxidation but impairs vascular function in small mesenteric arteries of the streptazocin-diabetic rat. Diabetologia 1998; 41: 148-56.